Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
2018
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
Networking Rank (Reputation):	> 1000
2012
Criterium:	Position:
Overall Score:	900-1000
Total Project Funding per Partner:	500-600
Total Number of Projects:	68
Total Project Funding:	600-700
Networking Rank (Reputation):	800-900
Networking Rank (Reputation):	800-900
Partner Constancy:	46
Project Leadership Index:	75
Diversity Index:	60
2007
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2020	0	11.773.000	299.658		1
2018	0	12.247.620	734.970		2
2012	0	17.970.946	1.693.219		3

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
GENETHON	4
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	2
FONDAZIONE TELETHON	2
MEDIZINISCHE HOCHSCHULE HANNOVER	2
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA	2
UNIVERSITY COLLEGE LONDON	2
3P BIOPHARMACEUTICALS SL	1
ACADEMIC MEDICAL CENTRE AMSTERDAM	1
AMSTERDAM BIOTHERAPEUTICS UNIT	1
ASPHALION SL	1
ASSOCIATION FRANCAISE DE CRIGLER NAJJAR	1
ASTELLAS PHARMA EUROPE BV	1
AZIENDA OSPEDALIERA PAPA GIOVANNI XXIII	1
BAYER	1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	1
CENTRO DE NEUROCIENCIAS E BIOLOGIACELULAR ASSOCIACAO	1
COMMISSARIAT A L'ENERGIE ATOMIQUE	1
DEUTSCHES KREBSFORSCHUNGSZENTRUM	1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE	1
EUROPAEISCHES INSTITUT FUER FORSCHUNG UND ENTWICKLUNG VON TRANSPLANTATIONSSTRATEGIEN	1
FINOVATIS	1
GATC BIOTECH	1
GEORG SPEYER HAUS CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT	1
HACETTEPE UNIVERSITESI	1
HET ROTTERDAMS OOGHEELKUNDIG INSTITUUT BV	1
HOTSWAP STOCKHOLM AB	1
IGEA	1
INFORMA	1
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE	1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	1
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA	1
INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ	1
JANSSEN PHARMACEUTICA NV	1
KLINIKUM DER JOHANN WOLFGANG GOETHE UNIVERSITAET	1
LONZA	1
LUND UNIVERSITY	1
LYSOGENE	1
MAGISTRAT DER STADT WIEN	1
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN	1
MC TOXICOLOGY CONSULTING	1
MIMETAS BV	1
NOVARTIS PHARMA	1
NOVARTIS PHARMA	1
NOVO NORDISK	1
PAUL EHRLICH INSTITUT	1
PFIZER LIMITED	1
PHARMACOIDEA FEJLESZTO ES SZOLGALTATO KFT	1
REGENX BIOSCIENCES LLC	1
REITHERA	1
RHEINISCH WESTFAELISCHE TECHNISCHE HOCHSCHULE AACHEN	1
SANOFIAVENTIS	1
SPARK THERAPEUTICS INC	1
STICHTING OOGZIEKENHUIS ROTTERDAM	1
SYNVACCINE	1
TAKEDA PHARMACEUTICALS INTERNATIONAL	1
TAKIS	1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	1
THE ROSALIND FRANKLIN INSTITUTE	1
THE UNIVERSITY OF LIVERPOOL	1
THE UNIVERSITY OF SHEFFIELD	1
UD GENOMED MEDICAL GENOMIC TECHNOLOGIES KUTATAS FEJLESZTESI ES SZOLGALTATO KFT	1
UNIVERSIDAD DE NAVARRA	1
UNIVERSITA DEGLI STUDI DELLA CAMPANIA LUIGI VANVITELLI	1
UNIVERSITa DEGLI STUDI DI NAPOLI 'FEDERICO II'	1
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II	1
UNIVERSITAET ZUERICH	1
UNIVERSITAETSKLINIKUM AACHEN	1
UNIVERSITAETSKLINIKUM HEIDELBERG	1
UNIVERSITE DE GENEVE	1
UNIVERSITY OF CAMBRIDGE	1
UNIVERSITY OF EASTERN FINLAND	1
UNIVERSITY OF LEICESTER	1
VISCOFAN	1

Constancy:

Total number of partners: 82
Partner loyalty:
Frequent Partner: (> 2 projects): 4
Rare Partner: 78
Frequent / Rare Partner Ratio: 0.05

Project overview:

Start date	Project	acronym	role	funding	partners
2020-11-01	Accelerating Research & Development for Advanced Therapies	ARDAT	participant	11.773.000	34
2018-01-01	Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome	CureCN	participant	6.249.104	11
2018-01-01	Clinical trial of gene therapy with dual AAV vectors for retinitis pigmentosa in patients with Usher syndrome type IB	UshTher	participant	5.998.516	9
2012-12-01	Clinical trial of gene therapy for MPS VI - a severe lysosomal storage disorder	MEUSIX	participant	5.995.041	8
2012-12-01	Gene Therapy for X-linked Chronic Granulomatous Disease (CGD)	NET4CGD	participant	5.999.607	11
2012-11-01	"Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD)"	TARGETAMD	participant	5.976.298	15

Alias institution names:

GENOSAFE SAS

GENOSAFE SAS - France